CRVS vs. HSHP

Last updated Jun 4, 2026

CRVS (Corvus Pharmaceuticals, Inc.) and HSHP (Himalaya Shipping Ltd.) are both stocks. CRVS operates in Biotechnology (Healthcare), while HSHP operates in Marine Shipping (Industrials). Over the past 3 years, CRVS returned 53.62%/yr vs 45.05%/yr for HSHP. At a 0.10 correlation, their price movements are largely independent.

Performance

CRVS vs. HSHP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corvus Pharmaceuticals, Inc. (CRVS) and Himalaya Shipping Ltd. (HSHP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRVS achieves a 50.65% return, which is significantly lower than HSHP's 61.64% return.

CRVS

• 1D: -0.77%
• 1M: -27.59%
• YTD: 50.65%
• 6M: 37.44%
• 1Y: 181.55%
• 3Y*: 53.62%
• 5Y*: 33.95%
• 10Y*: -2.20%

HSHP

• 1D: -1.91%
• 1M: 2.39%
• YTD: 61.64%
• 6M: 48.14%
• 1Y: 153.83%
• 3Y*: 45.05%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRVS vs. HSHP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
CRVS Corvus Pharmaceuticals, Inc.	50.65%	43.93%	203.98%	107.06%	-5.35%
HSHP Himalaya Shipping Ltd.	61.64%	96.10%	-23.53%	37.12%	-1.96%

Correlation

The correlation between CRVS and HSHP is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (All Time) Calculated using the full available price history since Oct 26, 2022	0.10

Fundamentals

Market Cap CRVS : $1.04B HSHP : $675.17M
EPS CRVS : -$0.53 HSHP : $0.63
PB Ratio CRVS : 4.34 HSHP : 4.33
Total Revenue (TTM) CRVS : $0.00 HSHP : $143.50M
Gross Profit (TTM) CRVS : -$26.00K HSHP : $98.40M
EBITDA (TTM) CRVS : -$47.43M HSHP : $101.44M

Return for Risk

CRVS vs. HSHP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRVS

CRVS Risk / Return Rank: 85
CRVS Sharpe Ratio Rank: 72
CRVS Sortino Ratio Rank: 95
CRVS Omega Ratio Rank: 92
CRVS Calmar Ratio Rank: 84
CRVS Martin Ratio Rank: 82

HSHP

HSHP Risk / Return Rank: 96
HSHP Sharpe Ratio Rank: 97
HSHP Sortino Ratio Rank: 95
HSHP Omega Ratio Rank: 93
HSHP Calmar Ratio Rank: 97
HSHP Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRVS vs. HSHP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Himalaya Shipping Ltd. (HSHP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRVS	HSHP	Difference
Sharpe ratio Return per unit of total volatility	1.01	3.92	-2.91
Sortino ratio Return per unit of downside risk	4.18	4.18	-0.01
Omega ratio Gain probability vs. loss probability	1.47	1.52	-0.05
Calmar ratio Return relative to maximum drawdown	3.33	9.94	-6.62
Martin ratio Return relative to average drawdown	7.50	23.09	-15.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRVS vs. HSHP - Sharpe Ratio Comparison

The current CRVS Sharpe Ratio is 1.01, which is lower than the HSHP Sharpe Ratio of 3.92. The chart below compares the historical Sharpe Ratios of CRVS and HSHP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRVS	HSHP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.01	3.92	-2.91
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.26	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.02	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	0.92	-0.93

Drawdowns

CRVS vs. HSHP - Drawdown Comparison

The maximum CRVS drawdown since its inception was -96.97%, which is greater than HSHP's maximum drawdown of -51.51%. Use the drawdown chart below to compare losses from any high point for CRVS and HSHP.

Drawdown Indicators

	CRVS	HSHP	Difference
Max Drawdown Largest peak-to-trough decline	-96.97%	-51.51%	-45.46%
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	-15.57%	-39.37%
Max Drawdown (3Y) Largest decline over 3 years	-72.02%	-51.51%	-20.51%
Max Drawdown (5Y) Largest decline over 5 years	-92.40%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-96.97%	—	—
Current Drawdown Current decline from peak	-54.55%	-10.66%	-43.89%
Average Drawdown Average peak-to-trough decline	-69.33%	-14.82%	-54.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.34%	6.69%	+17.65%

Volatility

CRVS vs. HSHP - Volatility Comparison

Corvus Pharmaceuticals, Inc. (CRVS) has a higher volatility of 23.60% compared to Himalaya Shipping Ltd. (HSHP) at 16.82%. This indicates that CRVS's price experiences larger fluctuations and is considered to be riskier than HSHP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRVS	HSHP	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.60%	16.82%	+6.78%
Volatility (6M) Calculated over the trailing 6-month period	112.05%	31.63%	+80.42%
Volatility (1Y) Calculated over the trailing 1-year period	180.95%	39.58%	+141.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	131.04%	42.63%	+88.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.15%	42.63%	+68.52%

Dividends

CRVS vs. HSHP - Dividend Comparison

CRVS has not paid dividends to shareholders, while HSHP's dividend yield for the trailing twelve months is around 4.04%.

Position	TTM	2025	2024
CRVS Corvus Pharmaceuticals, Inc.	0.00%	0.00%	0.00%
HSHP Himalaya Shipping Ltd.	4.04%	3.57%	9.88%

Financials

Frequently Asked Questions

Can I hold both CRVS and HSHP in my portfolio?

CRVS and HSHP have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRVS or HSHP?

CRVS has higher volatility (23.60%) compared to HSHP (16.82%). In terms of maximum drawdown, CRVS dropped -96.97% vs HSHP's -51.51%.

Which has better risk-adjusted returns?

HSHP currently has the higher Sharpe Ratio (3.92 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.